In last trading session, Generation Bio Co (NASDAQ:GBIO) saw 0.52 million shares changing hands with its beta currently measuring 2.69. Company’s recent per share price level of $0.61 trading at -$0.01 or -0.78% at ring of the bell on the day assigns it a market valuation of $40.76M. That closing price of GBIO’s stock is at a discount of -662.3% from its 52-week high price of $4.65 and is indicating a premium of 1.64% from its 52-week low price of $0.60.
For Generation Bio Co (GBIO), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.86. Splitting up the data highlights that, out of 1 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 1 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.25 in the current quarter.
Generation Bio Co (NASDAQ:GBIO) trade information
Upright in the red during last session for losing -0.78%, in the last five days GBIO remained trading in the red while hitting it’s week-highest on Tuesday, 02/18/25 when the stock touched $0.61 price level, adding 18.84% to its value on the day. Generation Bio Co’s shares saw a change of -42.43% in year-to-date performance and have moved -10.26% in past 5-day. Generation Bio Co (NASDAQ:GBIO) showed a performance of -36.15% in past 30-days.
Generation Bio Co (GBIO) estimates and forecasts
This year revenue growth is estimated to rise 207.23% from the last financial year’s standing.
6 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 2.92M for the same. And 4 analysts are in estimates of company making revenue of 1.4M in the next quarter. Company posted 2.88M and 4.06M of sales in current and next quarters respectively a year earlier.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -20.44% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 0.39% while estimates for its earnings growth in next 5 years are of 22.35%.
Generation Bio Co (NASDAQ:GBIO)’s Major holders
PRICE T ROWE ASSOCIATES INC /MD/ is the top institutional holder at GBIO for having 9.51 million shares of worth $26.83 million. And as of 2024-06-30, it was holding 14.3205 of the company’s outstanding shares.
The second largest institutional holder is ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC, which was holding about 8.28 million shares on 2024-06-30. The number of shares represents firm’s hold over 12.4628 of outstanding shares, having a total worth of $23.35 million.
On the other hand, Price (T.Rowe) New Horizons Fund and Fidelity Growth Company Fund are the top two Mutual Funds which own company’s shares. As of Sep 30, 2024 , the former fund manager was holding 5.34 shares of worth $3.26 million or 8.00% of the total outstanding shares. The later fund manager was in possession of 1.78 shares on Dec 31, 2024 , making its stake of worth around $1.08 million in the company or a holder of 2.66% of company’s stock.
